about
IgG4-related disease: current challenges and future prospectsIgG4-related membranous glomerulonephritis and generalized lymphadenopathy without pancreatitis: a case report.A rare and emerging entity: Sinonasal IgG4-related sclerosing disease.Gallium SPECT/CT in evaluation of IgG4-related disease: A case report and literature reviewCharacterizing IgG4-related disease with ¹⁸F-FDG PET/CT: a prospective cohort study.Autoimmune pancreatitis in the context of IgG4-related disease: review of imaging findingsIgG4-related disease and hypertrophic pachymeningitis.Extensive Metastatic Cholangiocarcinoma Associated With IgG4-Related Sclerosing Cholangitis Misdiagnosed as Isolated IgG4-Related Sclerosing Cholangitis: A Case Report and Literature Review.Neurological Manifestations of IgG4-Related DiseaseImmunoglobulin G4-related constrictive pericarditis identified by cytological examination of pericardial effusion: a case report.IgG4-Related disease simulating paraneoplastic syndrome: Role of 18FDG PET/CT imaging.Seventy FDG-PET/CT Cases in Which Nuclear Medicine Physicians Suspected Lymphoma: How Reliable Are We?Histopathologic Overlap between Fibrosing Mediastinitis and IgG4-Related Disease.Contrast-enhanced (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in immunoglobulin G4-related retroperitoneal fibrosis.18F- FDG PET/CT helps differentiate autoimmune pancreatitis from pancreatic cancer.Role of FDG-PET/CT in diagnosis of aortitis caused by Takayasu arteritis and IgG4-related systemic disease.IgG4-related disease in a Chinese cohort: a prospective study.Study of systemic disease IgG4. Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose -positron emission tomography/computed tomography for staging, selection of biopsy site, evaluation of treatment response and follow-up.Serum soluble interleukin-2 receptor as a biomarker in immunoglobulin G4-related disease.The Utility of FDG PET/CT in IgG4-Related Disease with a Focus on Coronary Artery Involvement.Clinical utility of (18) F-fluorodeoxyglucose/positron emission tomography in diagnosis of immunoglobulin G4-related sclerosing sialadenitis.Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease.IgG4-related Lung Pseudotumor and Pleural Inflammation with Autoimmune Hepatitis.Diffuse large B-cell lymphoma of the lacrimal sac arising from a patient with IgG4-related disease.Total lesion glycolysis as an IgG4-related disease activity marker.Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study.Development of IgG4-related disease 10 years after chemotherapy for diffuse large B cell lymphoma and longstanding bronchial asthma.Diagnosis and Treatment of IgG4-Related Disease.Invasive cervical cancer accompanied by IgG4-related disease.Role of F-18 FDG PET/CT in assessing IgG4-related disease with inflammation of head and neck glands.IgG4-related disease of pulmonary artery causing pulmonary hypertension.
P2860
Q26765309-02233491-1132-469A-8BD3-578E38930A64Q33441399-8B4CC7A7-F535-4B67-A2D1-1AA6718BBCC0Q33564120-B4876CC4-2CDF-4D4C-873C-D8C217D45237Q33595377-F1F63795-E366-4906-A288-20126D5BFFBDQ33870773-57795CE3-2319-49F0-B996-E5A104F2952EQ34467195-4EBB6672-625C-48A2-9F6B-D97E86F39962Q36008965-9A9C4D82-C5EB-4E31-A433-A037883C38BFQ37016845-8FD797CA-7EC5-4FE7-BB86-1B0012A24F76Q37736043-444E1C11-5574-44B6-83AE-F39758DB0BEEQ39616948-6FB687AD-29D1-45D1-BF5A-936B29B23985Q40046431-DBDE879F-F523-4C01-B316-605AD1DCE732Q41053853-22E951FC-53C0-411C-B069-FA49CE8D0B73Q41839241-04BA8913-E7C8-49AA-8F52-0C3FCDF68264Q42269738-72D45EC6-4729-4983-AB3C-6DAA34E9A3DDQ42644013-FAB8DF64-9BF5-4F27-BCE0-48F9325F814DQ43569415-A1C6275A-2AD4-45EA-A3CE-3D8E503F7F14Q44421144-D6B05F17-0721-4772-9724-971FDA214617Q47128044-E3931DF5-05AF-421D-B001-F3A88E72981EQ47282483-1E5AF15D-609D-496B-A3FB-5E6FF4A40FD2Q47547175-E0147A71-0669-48AB-8458-C6CAFF27C74DQ47617149-F15AE01A-E9FF-4523-BFBC-DC6600E16C1AQ47699328-2B699DB8-8EE3-4C26-82C3-76DC7F878465Q47743460-F2DB72A4-7DE4-4645-8C2B-397216461E92Q50433579-01B30A8D-4284-453A-85BB-796D7D34BC4CQ50608230-DDB2BBFB-8771-45DD-A00E-ADB67357AA66Q50850657-1093FD1A-AA7D-4320-AF49-339225EA370BQ51000013-23847AEC-80CF-4A80-B4EF-F3C6E00C8BD1Q51137683-24D25717-B439-42D5-BF07-EC3FB6D8CF01Q52982664-F8DB5555-0EF5-4109-B43B-82CCC31D9FD3Q53015035-3E602BC6-D727-4CEC-ADC6-9049F9657646Q55369345-FA6E4EE9-3F15-44C4-8ABD-0BFBE7D72214
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Utility of FDG PET/CT in IgG4-related systemic disease.
@en
Utility of FDG PET/CT in IgG4-related systemic disease.
@nl
type
label
Utility of FDG PET/CT in IgG4-related systemic disease.
@en
Utility of FDG PET/CT in IgG4-related systemic disease.
@nl
prefLabel
Utility of FDG PET/CT in IgG4-related systemic disease.
@en
Utility of FDG PET/CT in IgG4-related systemic disease.
@nl
P2093
P1433
P1476
Utility of FDG PET/CT in IgG4-related systemic disease.
@en
P2093
P304
P356
10.1016/J.CRAD.2011.10.011
P577
2011-11-26T00:00:00Z